A leader in global health
Mr König joins to lead late-stage drug development company developing proprietary fixed dose combina...
Differences in how blood pressure affects the risk of dementia in men and women may provide clues to...
When clinical trials become a normal part of care options for patients with unmet needs, both resear...
For George Health, 2019 and 2020 were watershed years. Multiple investors stepped forward to complete a capital raise of $53 million to back George Health’s ‘profit with purpose’ vision: improving and lengthening people’s lives, boosting health system sustainability and generating strong financial returns.
Read our year in review in The George Institute’s Annual Report 2020.